Provided that anti-VEGF treatment is available for a patient with BRVO and that macular oedema can be successfully suppressed, it is likely that there would be a correlation between retinal sensitivity at 12 months and PD evaluated one month after the first anti-VEGF injection when investigated in a point-by-point manner. This evidence concerns the gene VEGFA and macular retinal edema.